Showing results (121-130 of 432) with videos related to

Sort By:
Pageof 44
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2010
Duration of first off-treatment interval is prognostic for time to castration resistance and death in men with biochemical relapse of prostate cancer treated on a prospective trial of intermittent androgen deprivationEvan Y Yu, Roman Gulati, Donatello Telesca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2011
Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variantsElahe A Mostaghel, Brett T Marck, Stephen R Plymate, et al.
Plos One|May 5, 2012
Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tractsStephanie Bertram, Adeline Heurich, Hayley Lavender, et al.
Plos One|May 27, 2020
Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapiesLaura S Graham, Bruce Montgomery, Heather H Cheng, et al.
Cancer Research|September 19, 2019
PEG10 Promoter-Driven Expression of Reporter Genes Enables Molecular Imaging of Lethal Prostate CancerMariya Shapovalova, John K Lee, Yingming Li, et al.
Asian Journal of Urology|December 22, 2017
Mismatch repair enzyme expression in primary and castrate resistant prostate cancerBelinda Nghiem, Xiaotun Zhang, Hung-Ming Lam, et al.
Plos Biology|December 5, 2008
Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressorJean-Philippe Coppé, Christopher K Patil, Francis Rodier, et al.
The Journal of Biological Chemistry|May 31, 2002
Evidence that the human gene for prostate short-chain dehydrogenase/reductase (PSDR1) encodes a novel retinal reductase (RalR1)Natalia Y Kedishvili, Olga V Chumakova, Sergei V Chetyrkin, et al.
Cancer Research|June 4, 2008
Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growthR Bruce Montgomery, Elahe A Mostaghel, Robert Vessella, et al.
Urology|September 18, 2009
Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepositoryLisa F Newcomb, James D Brooks, Peter R Carroll, et al.
Pageof 44